Abionic announces successful completion of sepsis trial

Abionic announces successful completion of sepsis trial

13.9.2019 – Sepsis claims more lives than prostate cancer, breast cancer and AIDS combined. Early diagnosis is key for a successful treatment. The results of a study using Abionic’s novel point-of-care sepsis test show an anticipation of 24 hours for the diagnosis of sepsis compared to current standard of care.

read more